Please provide your email address to receive an email when new articles are posted on . Biologic therapy requires standardization for the treatment of musculoskeletal conditions. Surgeons must ...
In the first part of our FDA: Drug & Device Team’s series on biological products regulation, we explain what qualifies as a “biological product” and how the Food and Drug Administration classifies ...
Ultimately, from among these various proposals, Congress in December 2020 passed the BPPT, which added section 351(k)(9) to the Public Health Service (“PHS”) Act (42 U.S.C. § 262(k)(9)). Prior to the ...
Once the active ingredient is defined, an Applicant must select which patent, or patents, to put forward for extension. The statute permits only one PTE per regulatory review period, so the choice is ...
Biologic drugs account for a disproportionate share of the increase in pharmaceutical spending in the US and worldwide. Against this backdrop, many look to the expanding market for ...
HONG KONG, Nov. 16, 2021 /PRNewswire/ -- The Centurium Capital-led privatization of leading plasma-based biopharmaceutical company China Biologic Products Holdings Inc. ("China Biologic" or the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results